Skip to main navigation Skip to main content

CEEM : Clinical and Experimental Emergency Medicine

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Images in Emergency Medicine
Imaging

Diffuse incidental dural calcifications

Clinical and Experimental Emergency Medicine 2024;11(3):316-317.
Published online: May 23, 2024

Department of Emergency Medicine, Rush University Medical Center, Chicago, IL, USA

Correspondence to Michael Gottlieb Department of Emergency Medicine, Rush University Medical Center, 1620 W Harrison St, Chicago, IL 60612, USA Email: michaelgottliebmd@gmail.com
• Received: April 11, 2024   • Revised: April 11, 2024   • Accepted: May 14, 2024

Copyright © 2024 The Korean Society of Emergency Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).

  • 4,032 Views
  • 67 Download
prev next
What is already known
Diffuse dural calcifications may be seen on incidental imaging and can be associated with hyperparathyroidism, vitamin D intoxication, Gorlin syndrome, hypertelorism, Maroteaux type brachyolmia, myotonic dystrophy, renal failure, and malignancy.
What is new in the current study
This case highlights the importance of diffuse dural calcifications as an incidental finding that requires referral for endocrinologic evaluation.
A 30-year-old woman presented with severe headache and left flank pain after a motor vehicle collision. On examination, she had moderate tenderness to palpation to her left flank but an otherwise unremarkable examination with no focal neurologic deficits. Complete blood count, complete metabolic panel, and lipase were unremarkable (Table 1). She had a normal computed tomography (CT) of the abdomen/pelvis. A noncontrast CT of the head was also obtained (Fig. 1).
The CT of the head demonstrated dense calcifications of the dura along the bilateral cerebral convexities, falx, and tentorial leaflets concerning for hyperparathyroidism. Excess secretion of parathyroid hormone leads to hypercalcemia through increased bone resorption, increased intestinal absorption, and decreased urinary excretion of calcium. It is frequently diagnosed after the fifth decade of life by asymptomatic lab abnormality with common clinical manifestations being renal stones and decreased bone mineral density [1]. The presence of cerebral calcifications as a sequela of hyperparathyroidism is rare. The differential diagnosis includes vitamin D intoxication, Gorlin syndrome (nevoid basal cell carcinoma syndrome), hypertelorism, Maroteaux type brachyolmia, myotonic dystrophy, renal failure, and malignancy [2]. This patient’s age also raised suspicion for Gorlin syndrome as 90% of patients have ectopic calcification by age of 30 years [3].
Based upon the CT, we sent a parathyroid hormone level, which was 214 pg/mL (normal range, 10–55 pg/mL). She had no history of basal cell carcinoma, so Gorlin syndrome was deemed less likely. She was diagnosed with hyperparathyroidism and referred to endocrinology for further management with a plan for parathyroidectomy. This case highlights the importance of clinicians’ awareness of diffuse dural calcifications as an incidental finding that requires referral for endocrinologic evaluation.
Informed consent for publication of the research details and clinical images was obtained from the patient.

Conflicts of interest

The authors have no conflicts of interest to declare.

Funding

The authors received no financial support for this study.

Data availability

Data sharing is not applicable as no new data were created or analyzed in this study.

Author contributions

Conceptualization: MG; Investigation: all authors; Project administration: all authors; Supervision: MG; Visualization: all authors; Writing–original draft: all authors; Writing–review & editing: all authors. All authors read and approved the final manuscript.

Fig. 1.
(A–C) Computed tomography scans of the head with calcifications (arrows) of the dura along the bilateral cerebral convexities, falx, and tentorial leaflets.
ceem-24-234f1.jpg
Table 1.
Patient laboratory values from complete metabolic panel
Table 1.
Laboratory test Value
Sodium (mmol/L) 138
Potassium (mmol/L) 3.5
Chloride (mmol/L) 107
Bicarbonate (mmol/L) 25
Blood urea nitrogen (mg/dL) 11
Creatinine (mg/dL) 1.09
Glucose (mg/dL) 98
Albumin (g/dL) 3.7
Calcium (mg/dL) 9.3
Magnesium (mg/dL) 2.1
Phosphorus (mg/dL) 3.7
Total protein (g/dL) 8.2
Total bilirubin (mg/dL) 0.7
Alkaline phosphatase (U/L) 103
Aspartate transaminase (U/L) 10
Alanine transaminase (U/L) 16
  • 1. Pyram R, Mahajan G, Gliwa A. Primary hyperparathyroidism: skeletal and non-skeletal effects, diagnosis and management. Maturitas 2011;70:246-55.
  • 2. Debnath J, Satija L, George RA, Vaidya A, Sen D. Computed tomographic demonstration of unusual ossification of the falx cerebri: a case report. Surg Radiol Anat 2009;31:211-3.
  • 3. Evans DG, Oudit D, Smith MJ, et al. First evidence of genotype-phenotype correlations in Gorlin syndrome. J Med Genet 2017;54:530-6.

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Diffuse incidental dural calcifications
Clin Exp Emerg Med. 2024;11(3):316-317.   Published online May 23, 2024
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Diffuse incidental dural calcifications
Clin Exp Emerg Med. 2024;11(3):316-317.   Published online May 23, 2024
Close

Figure

  • 0
Diffuse incidental dural calcifications
Image
Fig. 1. (A–C) Computed tomography scans of the head with calcifications (arrows) of the dura along the bilateral cerebral convexities, falx, and tentorial leaflets.
Diffuse incidental dural calcifications
Laboratory test Value
Sodium (mmol/L) 138
Potassium (mmol/L) 3.5
Chloride (mmol/L) 107
Bicarbonate (mmol/L) 25
Blood urea nitrogen (mg/dL) 11
Creatinine (mg/dL) 1.09
Glucose (mg/dL) 98
Albumin (g/dL) 3.7
Calcium (mg/dL) 9.3
Magnesium (mg/dL) 2.1
Phosphorus (mg/dL) 3.7
Total protein (g/dL) 8.2
Total bilirubin (mg/dL) 0.7
Alkaline phosphatase (U/L) 103
Aspartate transaminase (U/L) 10
Alanine transaminase (U/L) 16
Table 1. Patient laboratory values from complete metabolic panel